ArticleFrontiers in pharmacology2021

Designing Short Peptides to Block the Interaction of SARS-CoV-2 and Human ACE2 for COVID-19 Therapeutics.

Abdul Basit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.